Managing patients on endocrine therapy: Focus on quality-of-life issues
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 1, 2006
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents, Hormonal (MeSH)
- Aromatase Inhibitors (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Ovary (MeSH)
- Postmenopause (MeSH)
- Quality of Life (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Receptors, Estrogen (MeSH)
- Receptors, Progesterone (MeSH)
- Tamoxifen (MeSH)
published in
- Clinical Cancer Research Journal